Xencor to Present at Upcoming Investor Conferences

first_img By Digital AIM Web Support – February 4, 2021 Previous articlePersonalis to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceNext articleDistrict, Harvard to work on tutoring contracts Digital AIM Web Support Facebook Local NewsBusiness Twitter MONROVIA, Calif.–(BUSINESS WIRE)–Feb 4, 2021– Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming investor conferences:Guggenheim Healthcare Talks | 2021 Oncology DaysConference Dates: February 11-12, 2021Presentation Date: Thursday, February 11, 2021Presentation Time: 1:00 p.m. EST / 10:00 a.m. PST WhatsApp Facebook Pinterest TAGS  Pinterest WhatsApp Twitter 10th Annual SVB Leerink Global Healthcare Conference Conference Dates: February 22-26, 2021Presentation Date: Wednesday, February 24, 2021Presentation Time: 3:00 p.m. EST / 12:00 p.m. PST Live webcasts of the presentations will be available under “Events & Presentations” in the Investors section of the Company’s website located at www.xencor.com. Replays will be posted on the Xencor website approximately one hour after the live event and will be available for at least 30 days. About Xencor, Inc. Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 20 candidates engineered with Xencor’s XmAb ® technology are in clinical development internally and with partners. Xencor’s XmAb antibody engineering technology enables small changes to the structure of monoclonal antibodies resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com. View source version on businesswire.com:https://www.businesswire.com/news/home/20210204006030/en/ CONTACT: Charles Liles [email protected] Contact Jason I. Spark Canale Communications 619-849-6005 [email protected] KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH SOURCE: Xencor, Inc. Copyright Business Wire 2021. PUB: 02/04/2021 04:01 PM/DISC: 02/04/2021 04:01 PM http://www.businesswire.com/news/home/20210204006030/en Xencor to Present at Upcoming Investor Conferenceslast_img read more